AAM
EXAS

Azzad Asset Management’s Exact Sciences EXAS Stock Holding History

Azzad Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,229
Closed -$209K – 324
2022
Q4 		$209K Sell
4,229
-5,313
-56% -$217K 0.03% 302
2022
Q3 		$430K Sell
9,542
-13,117
-58% -$541K 0.04% 353
2022
Q2 		$998K Buy
22,659
+3,713
+20% +$199K 0.1% 273
2022
Q1 		$1.32M Buy
18,946
+853
+5% +$62.4K 0.19% 193
2021
Q4 		$1.41M Buy
18,093
+833
+5% +$73.5K 0.19% 188
2021
Q3 		$1.65M Buy
17,260
+15,482
+871% +$1.63M 0.24% 163
2021
Q2 		$221K Buy
+1,778
New +$212K 0.03% 315
2020
Q1 		– Sell
-4,514
Closed -$405K – 310
2019
Q4 		$405K Buy
4,514
+149
+3% +$13.1K 0.05% 319
2019
Q3 		$387K Buy
+4,365
New +$497K 0.05% 316

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Azzad Asset Management's EXAS Position: Q1 2023 in Review

Azzad Asset Management sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 4,229 shares — an estimated $209K sold.

Azzad Asset Management first reported a position in EXAS in Q3 2019 and held it in 9 quarters. The position peaked at $1.65M in Q3 2021. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Azzad Asset Management reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • Azzad Asset Management sold 4,229 Exact Sciences shares in Q1 2023, an estimated $209K.
  • Azzad Asset Management first reported a position in Exact Sciences in Q3 2019 and held it in 9 quarters.
  • Azzad Asset Management's Exact Sciences position peaked at $1.65M in Q3 2021.
  • 583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Azzad Asset Management's 13F filing for Q1 2023, filed 1 Apr 2024.